Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, marking the final act in Zymergen’s dramatic and brisk fall from grace. Signage is ...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Zymergen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Zymergen, a technology company unlocking the power of biology, announced today that it has raised 130 million USD in Series B funding led by SoftBank Group (TOKYO: ...
Less than four months after going public and being valued at more than $3 billion by Wall Street, Zymergen Inc. unleashed some bad news Tuesday afternoon, and was on pace to lose more than two-thirds ...
EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide Zymergen Z2 TM polyimide powder to 3D4Makers for ...
Shares of Zymergen soared as much as 85% on Thursday, helping the synthetic biology company recoup some of its massive losses from Wednesday. Zymergen plunged 76% yesterday after it said issues with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results